Indeed, a beneficial effect of intravenous administration of bone marrow-derived, 1α,25-dihydroxyvitamin D3 (vitD3)-treated tolDC loaded with myelin oligodendrocyte glycoprotein (MOG)40–55 peptide was demonstrated in a mouse model of experimental autoimmune encephalomyelitis (EAE) [4, 5]. The gene discussed is OMG; the disease is experimental autoimmune encephalomyelitis.